Related Experiment Video
Updated: May 29, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
[What the Hookah hides: An unknown cause of acute organized fibrinous pneumonia?]
Alejandro Álvarez-Muñoz1, Jesús Machuca-Aguado2, Rosa Rendón-García1
1Département de pathologie, hôpital universitaire Virgen-Macarena, Avda. Fedriani, 3, 41009 Séville, Espagne.
Abstract:
Acute organized fibrinous pneumonia (AOFP) is a rare entity, initially characterized by Beasley et al. in 2002. This report highlights an undocumented case of AOFP in a habitual hookah smoker. AOFP is distinguished by inflammatory infiltrates and intra-alveolar fibrin deposits, often associated with infectious and autoimmune processes, and recently linked to the use of electronic cigarettes and vaping. The involvement of hookah in this pathogenic mechanism suggests that inhalation of oil-rich compounds and high-temperature gases could cause similar alveolar damage. Early recognition of AOFP is essential in patients presenting with sudden dyspnea and pulmonary infiltrates unresponsive to antibiotic therapy. Diagnosis relies on biopsies confirming fibrin deposits, and prompt treatment with corticosteroids can lead to effective clinical and radiological resolution.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

